Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Silo Pharma (SILO) EBT Margin (2019 - 2025)

Silo Pharma (SILO) has disclosed EBT Margin for 7 consecutive years, with 4890.33% as the latest value for Q4 2025.

  • Quarterly EBT Margin rose 471036.0% to 4890.33% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 5863.5% through Dec 2025, up 22909.0% year-over-year, with the annual reading at 5863.5% for FY2025, 22909.0% up from the prior year.
  • EBT Margin hit 4890.33% in Q4 2025 for Silo Pharma, up from 6160.54% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 644539.63% in Q4 2021 to a low of 1344010.56% in Q3 2021.
  • Historically, EBT Margin has averaged 39443.17% across 5 years, with a median of 5161.15% in 2024.
  • Biggest five-year swings in EBT Margin: crashed -134059350bps in 2021 and later soared 133855566bps in 2022.
  • Year by year, EBT Margin stood at 644539.63% in 2021, then plummeted by -101bps to 9224.63% in 2022, then surged by 37bps to 5833.66% in 2023, then crashed by -65bps to 9600.69% in 2024, then skyrocketed by 49bps to 4890.33% in 2025.
  • Business Quant data shows EBT Margin for SILO at 4890.33% in Q4 2025, 6160.54% in Q3 2025, and 6681.24% in Q2 2025.